Clinical Trial News and Research

RSS

Administering immunotherapy alongside chemoradiation for advanced NSCLC appears to be safe and tolerable

Research from Rutgers Cancer Institute of New Jersey shows administering the immunotherapy drug pembrolizumab together with chemotherapy given at the same time as radiation treatment (chemoradiation) is safe and tolerable as a first-line therapy for patients with stage 3 non-small cell lung cancer.

21 Feb 2020

New drug offers hope for preserving brain cells for a time after stroke

After 50 years of research and the testing of over 1,000 drugs, there is new hope for preserving brain cells for a time after stroke.

21 Feb 2020

Global study shows long-term survival benefit for a subset of patients with advanced lung cancer

According to the results of a large, global study led by Yale Cancer Center researchers, even a tiny amount of a biomarker known as PD-L1 (programmed death-ligand1) can predict a long-term survival benefit from using pembrolizumab (Keytruda).

20 Feb 2020

Study exposes the Achilles' heel of deadly ccRCC tumors

An experimental drug already shown to be safe and help some patients with clear cell renal cell carcinoma, a deadly form of kidney cancer, effectively disables its molecular target.

20 Feb 2020

Intracranial stent appears to be safe and effective for reducing recurrent stroke risk

A brain stent appears safe and effective for reducing the risk of recurrent stroke in patients with cholesterol-clogged brain arteries, according to late breaking science presented today at the American Stroke Association's International Stroke Conference 2020.

20 Feb 2020

Wearable magnetic brain stimulation device could improve motor function in stroke patients

A non-invasive, wearable, magnetic brain stimulation device could improve motor function in stroke patients, according to preliminary late breaking science presented today at the American Stroke Association's International Stroke Conference 2020.

20 Feb 2020

StemBioSys announces acquisition of majority stake in Cartox

StemBioSys, Inc. and CarTox, Inc. are pleased to announce that StemBioSys has acquired a majority stake in Cartox. StemBioSys will acquire all remaining equity of Cartox subject to the achievement of certain milestones.

From StemBioSys 20 Feb 2020

Patient satisfaction and quality of life similar across all appendicitis treatments

A new study published in the journal JAMA Surgery in February 2020 shows that patients with acute appendicitis that were successfully treated either by antibiotics or by appendectomy had identical satisfaction with their treatment and identical quality of life over the long term. The patients who were first treated conservatively and then had appendectomy had lower satisfaction rates.

19 Feb 2020

Exploring how brain inflammation after stroke can be shaped to support recovery

University of Kentucky College of Medicine researcher Ann Stowe describes her career path as nontraditional. After earning a bachelor's degree in fine arts, Stowe decided to pursue graduate study in biomedical research instead of art history.

19 Feb 2020

Drugs targeting T cells may be effective in treating cerebral malaria

Researchers at the National Institutes of Health found evidence that specific immune cells may play a key role in the devastating effects of cerebral malaria, a severe form of malaria that mainly affects young children.

18 Feb 2020

Organs from hepatitis C-infected donors benefit many kidney patients

A new medical approach recommended by University of Cincinnati physician-researchers may reduce organ wait times, save money, boost quality of life and prolong life expectancy for kidney patients.

18 Feb 2020

Guideline-recommended diuretic linked to more side effects than similar antihypertensive drug

Chlorthalidone, the guideline-recommended diuretic for lowering blood pressure, causes more serious side effects than hydrochlorothiazide, a similarly effective diuretic, according to a new study led by researchers at Columbia University Irving Medical Center.

17 Feb 2020

Combination therapy for pediatric low-grade gliomas shows promise in mice

In experiments with human cells and mice, researchers at the Johns Hopkins Kimmel Cancer Center report evidence that combining the experimental cancer medication TAK228 (also called sapanisertib) with an existing anti-cancer drug called trametinib may be more effective than either drug alone in decreasing the growth of pediatric low-grade gliomas.

17 Feb 2020

Simple blood test measures the body's immune response to improve ovarian cancer diagnosis

Researchers have developed a simple blood test that measures the body's own immune response to improve diagnosis of ovarian cancer.

17 Feb 2020

UCLA researcher designs ways for immune cells to 'outsmart' solid tumors

Yvonne Chen engineers immune cells to target their most evasive enemy: cancer. New cancer immunotherapies generate immune cells that are effective killers of blood cancers, but they have a hard time with solid tumors.

16 Feb 2020

Daily intake of non-fried potato linked to better diet quality compared to refined grains

Potatoes are often equated with refined grains due to their carbohydrate content. Yet, potatoes contain fiber, resistant starch, and key micronutrients that Americans need more of in their diet.

14 Feb 2020

Study finds no advantage in using two antibiotics to treat MRSA infections

A world-first clinical trial has called into question the effectiveness of using more than one antibiotic to treat the deadly 'super-bug', Methicillin-resistant staphylococcus aureus Bacteremia, commonly known as Golden Staph.

14 Feb 2020

FDA approves first oral immunotherapy treatment for peanut allergy in children, teens

The University of Chicago Medicine was part of a landmark clinical trial that led to approval by the U.S. Food and Drug Administration of the first oral immunotherapy treatment for peanut allergy in children and teens.

13 Feb 2020

Treating soft tissue sarcoma with shorter radiation treatment found to be safe, effective

A new study led by researchers at the UCLA Jonsson Comprehensive Cancer Center found that treating soft tissue sarcoma with radiation over a significantly shorter period of time is safe, and likely just as effective, as a much longer conventional course of treatment.

13 Feb 2020

NPF names Rush as National Center of Excellence for Pancreatic Cancer

The National Pancreas Foundation has named Rush University Medical Center as a National Center of Excellence for Pancreatic Cancer, a designation given to hospitals that have demonstrated the multi-disciplinary approach, social support and advanced research resources needed to successfully treat this devastating disease.

13 Feb 2020

Clinical Trial News and Research

Administering immunotherapy alongside chemoradiation for advanced NSCLC appears to be safe and tolerable

New drug offers hope for preserving brain cells for a time after stroke

Global study shows long-term survival benefit for a subset of patients with advanced lung cancer

Study exposes the Achilles' heel of deadly ccRCC tumors

Intracranial stent appears to be safe and effective for reducing recurrent stroke risk

Wearable magnetic brain stimulation device could improve motor function in stroke patients

StemBioSys announces acquisition of majority stake in Cartox

Patient satisfaction and quality of life similar across all appendicitis treatments

Exploring how brain inflammation after stroke can be shaped to support recovery

Drugs targeting T cells may be effective in treating cerebral malaria

Organs from hepatitis C-infected donors benefit many kidney patients

Guideline-recommended diuretic linked to more side effects than similar antihypertensive drug

Combination therapy for pediatric low-grade gliomas shows promise in mice

Simple blood test measures the body's immune response to improve ovarian cancer diagnosis

UCLA researcher designs ways for immune cells to 'outsmart' solid tumors

Daily intake of non-fried potato linked to better diet quality compared to refined grains

Study finds no advantage in using two antibiotics to treat MRSA infections

FDA approves first oral immunotherapy treatment for peanut allergy in children, teens

Treating soft tissue sarcoma with shorter radiation treatment found to be safe, effective

NPF names Rush as National Center of Excellence for Pancreatic Cancer

Event guide: 15th World Clinical Biomarkers & CDx Europe eBook

Latest eBooks

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Driving innovation in Korean drug development

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer